Graves Disease Clinical Trials, Growth, and Key Companies |Viridian Therapeutics, Immunovant Sciences GmbH, Apitope International NV, Sling Therapeutics, Novartis Pharmaceuticals.

DelveInsight Business Research LLP
(Las Vegas Nevada United States), DelveInsight’s “Graves’ Disease- Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Graves’ Disease pipeline landscape.

(Las Vegas Nevada United States), DelveInsight’s Graves’ Disease- Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Graves’ Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Graves Disease Pipeline Report

Over 8+ Companies and 10 + Pipeline Drugs for Graves Disease are in various stages of development, and their anticipated acceptance in the Graves Disease market would significantly increase market revenue. 

Leading Graves Disease companies developing novel drug candidates to improve the Graves Disease treatment landscape includes Viridian Therapeutics, Immunovant Sciences GmbH, Apitope International NV, Sling Therapeutics, Novartis Pharmaceuticals and many others.

Promising Graves Disease pipeline therapies in various stages of development include Batoclimab, Linsitinib, VRDN-001, and many others.

Graves Disease Overview

Graves’ Disease (GD) is an autoimmune disease that primarily affects the thyroid gland. It may also affect multiple other organs, including the eyes and skin. It is the most common cause of hyperthyroidism. Graves’ disease is caused by thyroid-stimulating immunoglobulin (TSI), also known as thyroid-stimulating antibody (TSAb). B lymphocytes primarily synthesize Thyroid stimulating immunoglobulin within the thyroid cells, but it can also be synthesized in lymph nodes and bone marrow. B lymphocytes are stimulated by T lymphocytes which get sensitized by antigens in the thyroid gland. Thyroid-stimulating immunoglobulin binds with the thyroid-stimulating hormone (TSH) receptor on the thyroid cell membrane and stimulates the action of the thyroid-stimulating hormone. It stimulates both, thyroid hormone synthesis and thyroid gland growth, causing hyperthyroidism and thyromegaly. Several environmental factors, including pregnancy (mainly postpartum), iodine excess, infections, emotional stress, smoking, and interferon alfa, trigger immune responses in susceptible genes to eventually cause Graves’ disease.

Graves Disease Pipeline Analysis: Drug Profile

Batoclimab: Immunovant Sciences GmbH

Batoclimab (IMVT-1401) is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). The FcRn receptor facilitates IgG recycling. Batoclimab enhances the degradation of IgG by targeting FcRn and preventing endogenous IgG from binding. This increased catabolism of IgG may curtail the harmful immune response exhibited by auto-antibodies. In nonclinical studies and in clinical trials conducted, batoclimab was observed to reduce IgG antibody levels. High levels of pathogenic IgG antibodies drive a variety of autoimmune diseases and, as a result, the company believes that this product candidate has the potential to address a variety of IgG-mediated autoimmune diseases as a self-administered subcutaneous injection. The drug is currently being investigated in the Phase III stage of development for the treatment of Graves’ Disease.

Discover more about the emerging Graves Disease drugs @ Graves DiseaseTreatment Drugs

Graves Disease Pipeline Therapies and Key Companies

ARO-AAT: Arrowhead Pharmaceuticals

And many others 

Graves Disease Pipeline Therapeutics Assessment


DelveInsight’s Report covers around 10+ products under different phases of clinical development like

Late-stage products (Phase III)

Mid-stage products (Phase II)

Early-stage product (Phase I) along with the details of

Pre-clinical and Discovery stage candidates

Discontinued & Inactive candidates


Route of Administration

Graves Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as





Intravenous/ Subcutaneous






Molecule Type

Products have been categorized under various Molecule types such as


Antisense oligonucleotides


Monoclonal antibody



Recombinant protein

Small molecule

Stem Cell


Product Type

Drugs have been categorized under various product types like Mono, Combination, and Mono/Combination.

Scope of the Graves Disease Pipeline Report 

Coverage: Global 

Key Graves Disease Companies: Viridian Therapeutics, Immunovant Sciences GmbH, Apitope International NV, Sling Therapeutics, Novartis Pharmaceuticals, and many others

Key Graves Disease Pipeline Therapies: Batoclimab, Linsitinib, VRDN-00, and many others 

Find out more about the Graves Disease treatment options in development @ Graves Disease Clinical Trials

Table of Contents

1. Graves Disease Introduction

2. Graves Disease Executive Summary

3. Graves Disease Overview

4. Graves Disease Pipeline Therapeutics

5. Graves Disease Late-Stage Products (Phase III)

6. Graves Disease Mid-Stage Products (Phase  II)

7. Graves Disease Early Stage Products (Phase  I/II)

8. Graves Disease  Preclinical Stage Products

9. Graves Disease Discovery Stage Products

10. Graves Disease Therapeutic Assessment

11. Graves Disease Inactive Products

12. Graves Disease Collaborations Assessment- Licensing / Partnering / Funding

13. Graves Disease Unmet Needs

14. Graves Disease Market Drivers and Barriers

15. Appendix

16. About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.


Smart public opinion research for everyone.

%d bloggers like this: